Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Tempest Therapeutics, Inc. Director's Dealing 2015

Jan 2, 2015

34632_dirs_2015-01-02_977ae098-088f-4042-a913-a3226ca78ef6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2014-12-31

Reporting Person: Dipp Michelle (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-31 Common Stock A 32052 Acquired 870622 Direct
2014-12-31 Common Stock F 15129 $44.22 Disposed 855493 Direct
2014-12-31 Common Stock F 6099 $44.22 Disposed 849394 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2820607 Indirect
Common Stock 50021 Indirect

Footnotes

F1: Represents the vesting of 100% of the performance conditions of the second annual installment of the restricted stock units ("RSUs") granted to the Reporting Person in December 2012.

F2: Shares withheld by the Registrant to satisfy statutory withholding requirements upon vesting of performance-based RSUs.

F3: Shares withheld by the Registrant to satisfy statutory withholding requirements upon vesting of time-based RSUs.

F4: Represents 818,492 shares of common stock and 30,902 RSUs.

F5: Longwood Fund GP, LLC is the general partner of Longwood Fund, LP. Voting and investment power with respect to the shares held by Longwood Fund, LP are vested in the Reporting Person, Richard Aldrich, and Christoph Westphal, M.D., Ph.D. (collectively, the "Managers"), the managers of Longwood Fund GP, LLC. Each of the Managers disclaims beneficial ownership of the shares held by Longwood Fund, LP, except to the extent of her respective pecuniary interest therein, and the inclusion of the Longwood Fund, LP shares in the report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or for any other purpose.

F6: The Managers are managers of Longwood Fund GP, LLC, the sole general partner of Longwood Fund, LP, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held by Longwood Fund GP, LLC. The Reporting Person disclaims beneficial ownership of the shares held by Longwood Fund GP, LLC, except to the extent of her respective pecuniary interest therein, and the inclusion of the Longwood Fund GP, LLC shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or any other purpose.